News and Announcements
The Elman Retina Group team enjoyed a surprise ice cream truck party to show our sincere appreciation for all the hard work that every single team member puts in every single day. It’s been a rough year for society due to COVID, but we are so proud of our ERG family for pushing through the tough times and keeping the top-notch work ethic, happiness, and empathy that makes the Elman Retina Group stand out from the rest. THANKS FOR YOUR HARD WORK AND DEDICATION!
We’re proud to announce that Dr. Elman was just voted #1 in the Vision Care section of the 2021 Baltimore Jewish Times’ annual “Best of Jewish Baltimore” competition.
To describe a Case of retinoblastoma that presented subtly as a pseudohypopyon in a child with preserved visual acuity.
Dr. Schechet and his team just published new research regarding macular hole closure with medical treatment.
Dr. Schechet and his team just published new research showing high rates of musculoskeletal disorders among practicing ophthalmologists. This is important for eye surgeons to know and prevent these problems with proper ergonomic behaviors.
Syphilitic retinitis presentations: punctate inner retinitis and posterior placoid chorioretinitis, published in the National Library of Medicine by Dr. Schechet and his co-authors. Click Here
‘Use of the King-Devick Variable Color Contrast Sensitivity Chart to differentiate stages of age-related macular degeneration,’ published in BMJ Open Ophthalmology by Dr. Schechet and his co-authors.
‘Bilateral retinal detachments presenting as manifestations of Vogt-Koyanagi-Harada syndrome,’ published in European Journal of Rheumatology by Dr. Schechet and his co-authors.
By SIDNEY A. SCHECHET, MD • MICHAEL J. ELMAN, MD • RAHUL KOMATI, MD • MICHAEL P. BLAIR, MD • SEENU M. HARIPRASAD, MD
January 1, 2020
Dr. Schechet presented an interesting surgical case and discussed the latest advancements in complex macular hole repair at the GBMC Ophthalmology Department’s CME evening event.
Dr. Schechet was in London for the 52nd international Retina Society meeting (http://www.retinasociety.org/). Here he is next to his research poster, in which he presented “Bevacizumab or Laser for Aggressive Posterior Retinopathy of Prematurity.” This study was recently published in a major peer-reviewed journal: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302568
On June 26, 2019, Michael J. Elman, M.D. was the guest of Professor Eric Souied, as Dr. Elman visited the world famous Ophthalmology Department at the University of Paris, Creitil. Here Dr. Elman (right) is pictured with Dr. Souied (left), Chief of Ophthalmology, and Dr. Alexandra Miere (center). During his visit, Dr. Elman was shown ground breaking methods for analyzing OCT angiograms, which Dr. Elman will now be able to use to aid in early diagnosis of macular diseases, such as age related macular degeneration, diabetic retinopathy and retinal vascular occlusion. Dr. Elman is among the first in the United States to use this revolutionary diagnostic technology developed by Dr. Souied and his team in France.
Michael J. Elman, M.D. was invited to serve as a moderator at the diabetes session of the biennial international retina meeting, Maculart 2019, in Paris on June 24, 2019. In addition, Dr. Elman presented the results of the “Exploratory Analysis of Change in Visual Fields Over 5 Years Among Eyes with Proliferative Diabetic Retinopathy” on behalf of the DRCR Retina Network.
Itay Kazaz and Dr. Michael Elman presenting research from the Elman Retina Group at the annual international ARVO meeting in Vancouver, May 2, 2019
April 23, 2019